NEW YORK (GenomeWeb) – Contract manufacturing firm Aldevron announced today that it has agreed to collaborate with non-profit foundation Myeloma Crowd to advance treatments and attempt to find a cure for multiple myeloma.

Aldevron has licensed minicircle DNA technology developed by Stanford University professor Mark Kay. Minicircles are small circular plasmid derivatives that are free of all prokaryotic vector parts. They have been used in research as transgene carriers for the genetic modification of mammalian cells.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.